Monographie - Epirubicin hydrochloride

Poslední aktualizace :
19/11/2024

Epirubicin hydrochloride

Chemický vzorec

Obchodní název

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Anthracine	Malajsie
Axirubicine	NÏmecko
Bendaepi	NÏmecko
Binarin	Mexiko
Bioepycina	Polsko
Crisabon	Argentina
Cuatroepi	Argentina
Ecclepia	Rumunsko
Elebicin	Mexiko
Ellence	USA
Epi Cell	NÏmecko
Epidoxo	Argentina, Chile, Venezuela
Epifil	Ekvádor
Epilem	Kolumbie, Mexiko
Epimedac	NÏmecko
Epirubicin	Austrálie, Belgie, Dánsko, Island, MaÔarsko, nový Zéland, Rakousko, Saúdská Arábie, Švédsko, Švýcarsko, Turecko, Velká Británie
Epirubicina	äpanÏlsko, Argentina, Ekvádor, Kolumbie, Mexiko, Rumunsko
Epirubicine	Belgie, Francie, Švýcarsko
Farmarubicin	Turecko
Farmorubicin	BrazÌlie, Dánsko, Finsko, Norsko, Rakousko, Saúdská Arábie, Švédsko, Švýcarsko, ÿecko
Farmorubicin CSV	Jihoafrická republika
Farmorubicin PFS	Chorvatsko, Polsko, Slovinsko
Farmorubicin RD	BrazÌlie, Polsko, rusky, Švýcarsko
Farmorubicin RTU	Nizozemsko
Farmorubicina	äpanÏlsko, BrazÌlie, Itálie, Portugalsko
Farmorubicine	Belgie, Francie
Pharmorubicin	Velká Británie

Odkazy : Epirubicin hydrochloride

	typ	uveřejnění
148	noviny	Dine T, Cazin JC, Gressier B, Luycks M, Brunet C, Cazin M, Goudaliez F, Mallevais ML, Toraub I. Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags. Pharm Weekbl [Sci] 1992 ; 14: 365-369.
525	noviny	De Vroe C, De Muynck C, Remon JP, Samsom M. A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters. Int J Pharm 1990 ; 65: 49-56.
683	noviny	Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C. Epirubicin stability in syringes and glass vials and evaluation of chemical contamination. Can J Hosp Pharm 1990 ; 43: 265-272.
686	noviny	Wood MJ, Irwin WJ, Scott DK. Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags. J Clin Pharm Ther 1990 ; 15: 279-289.
887	noviny	Pujol M, Munoz M, Prat J, Giona V, De Bolos J. Stability study of epirubicin in NaCl 0.9% injection. Ann Pharmacotherapy 1997 ; 31: 992-995.
1237	noviny	Keusters L, Stolk LML, Umans R, Van Asten P. Stability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at -20°C and thawing by microwave radiation. Pharm Weekbl [Sci] 1986 ; 8: 194-197.
1265	noviny	Wood MJ, Irwin WJ, Scott DK. Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography. J Clin Pharm Ther 1990 ; 15: 291-300.
1317	noviny	Adams PS, Haines-Hutt RF, Bradford E, Palmer A, Rowland CG. Pharmaceutical aspects of home infusion therapy for cancer patients. Pharm J 1987 ; 238: 476-478.
1662	noviny	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1823	noviny	Sewell GJ, Rigby-Jones AE, Priston MJ. Stability of intravesical epirubicin infusion: a sequential temperature study. J Clin Pharm Ther 2003 ; 28: 349-353.
1897	noviny	Sautou-Miranda V, Brigas F, Thibault M, Chopineau J. Compatibility of doxorubicin, daunorubicin and epirubicin with low-density polyethylene and polyvinyl chloride, and stability in various conditions of storage. EJHP 2001 ; 7, 3: 108-115.
1955	noviny	Trissel LA, Zhang Y. Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration. Ann Pharmacotherapy 2005 ; 39: 280-283.
2168	noviny	Ozdemir FA, Anilanmert B, Pekin M. Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution. Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534.
2257	Laboratoř	Stability of epirubicin "Ebewe" infusion solutions. Ebewe Pharma 2007
3473	noviny	Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B. Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization. Int J Pharm 2015 ; 495, 2: 956-962.
3474	Laboratoř	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3632	Laboratoř	Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics Hospira 2017
3670	noviny	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
3708	plakát	Sarakbi I, Thiesen J, Krämer I. Compatibility of epirubicin-loaded DC Beads with different contrast media. ECOP 2 Krakow 2014
3918	noviny	Sarakbi I, Krämer I. Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media. J Oncol Pharm Practice 2016 ; 22: 749-756.
4352	noviny	Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y. In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag. J Clin Pharm Ther 2019 ; 44: 875-882.

Mentions Légales